top of page
Highlights:
U.S. companies rushed to issue a record $32 billion in junk bonds in May to preempt looming tariff uncertainties
Search
Burning Cash, Going Global — How UK’s Vaccitech Used Nasdaq to Fund R&D and Step onto the World Stage
Business Overview｜Vaccine Innovation Born in Oxford Vaccitech, a biotech spinout from Oxford University, focuses on T-cell...
2 min read
From Virtual Brokerage to $3B Empire — EXPI’s Real Estate Disruption
In 2009, Glenn Sanford founded eXp Realty to replace traditional real estate offices with a fully cloud-based model. Agents work, train, and earn equity entirely online—cutting overhead and turning agents into shareholders.
1 min read
Virax Biolabs: An Emerging Force in Immune Diagnostics, Taking Off from Nasdaq
Founded in London during the pandemic, Virax Biolabs develops rapid tests and immune monitoring tools for viruses like COVID-19, monkeypox, and hepatitis B. Its core products—ViraxClear™ and Virax Immune™—support personalized preventive care.
2 min read
bottom of page